Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Carlos Matute

Showing results (21-30 of 204) with videos related to

Pageof 21
Sort By:
Glia|June 16, 2016
Adenosine A1 receptor inhibits postnatal neurogenesis and sustains astrogliogenesis from the subventricular zoneMonica Benito-Muñoz, Carlos Matute, Fabio Cavaliere
Stem Cells International|April 30, 2016
Organotypic Cultures as a Model to Study Adult Neurogenesis in CNS DisordersFabio Cavaliere, Monica Benito-Muñoz, Carlos Matute
Journal of Neurochemistry|July 27, 2005
A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptakeAinara Vallejo-Illarramendi, María Domercq, Carlos Matute
Journal of Neuroscience Methods|February 16, 2010
An organotypic culture model to study nigro-striatal degenerationFabio Cavaliere, Edurne San Vicente, Carlos Matute
Frontiers in Cellular Neuroscience|April 30, 2013
Neurotransmitter signaling in the pathophysiology of microgliaMaría Domercq, Nuria Vázquez-Villoldo, Carlos Matute
Frontiers in Cellular Neuroscience|March 3, 2020
Functional and Metabolic Characterization of Microglia Culture in a Defined MediumAlejandro Montilla, Alazne Zabala, Carlos Matute, et al.
Glia|October 6, 2005
Glutamate-mediated glial injury: mechanisms and clinical importanceCarlos Matute, María Domercq, María-Victoria Sánchez-Gómez
Glia|July 22, 2014
White matter injury: Ischemic and nonischemicRobert F Fern, Carlos Matute, Peter K Stys
Handbook of Clinical Neurology|March 27, 2025
Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington diseaseDmitry Lim, Carlos Matute, Fabio Cavaliere, et al.
Advances in Neurobiology|August 29, 2024
Role of Microglia in StrokeRaffaela Cipriani, Maria Domerq, Abraham Martín, et al.
Pageof 21

Showing results (21-30 of 204) with videos related to

Sort By:
Pageof 21
Glia|June 16, 2016
Adenosine A1 receptor inhibits postnatal neurogenesis and sustains astrogliogenesis from the subventricular zoneMonica Benito-Muñoz, Carlos Matute, Fabio Cavaliere
Stem Cells International|April 30, 2016
Organotypic Cultures as a Model to Study Adult Neurogenesis in CNS DisordersFabio Cavaliere, Monica Benito-Muñoz, Carlos Matute
Journal of Neurochemistry|July 27, 2005
A novel alternative splicing form of excitatory amino acid transporter 1 is a negative regulator of glutamate uptakeAinara Vallejo-Illarramendi, María Domercq, Carlos Matute
Journal of Neuroscience Methods|February 16, 2010
An organotypic culture model to study nigro-striatal degenerationFabio Cavaliere, Edurne San Vicente, Carlos Matute
Frontiers in Cellular Neuroscience|April 30, 2013
Neurotransmitter signaling in the pathophysiology of microgliaMaría Domercq, Nuria Vázquez-Villoldo, Carlos Matute
Frontiers in Cellular Neuroscience|March 3, 2020
Functional and Metabolic Characterization of Microglia Culture in a Defined MediumAlejandro Montilla, Alazne Zabala, Carlos Matute, et al.
Glia|October 6, 2005
Glutamate-mediated glial injury: mechanisms and clinical importanceCarlos Matute, María Domercq, María-Victoria Sánchez-Gómez
Glia|July 22, 2014
White matter injury: Ischemic and nonischemicRobert F Fern, Carlos Matute, Peter K Stys
Handbook of Clinical Neurology|March 27, 2025
Neuroglia in neurodegeneration: Alzheimer, Parkinson, and Huntington diseaseDmitry Lim, Carlos Matute, Fabio Cavaliere, et al.
Advances in Neurobiology|August 29, 2024
Role of Microglia in StrokeRaffaela Cipriani, Maria Domerq, Abraham Martín, et al.
Pageof 21